Matrix metalloproteinase-9 in peripheral blood eosinophils

International Archives of Allergy and Immunology

Volumn 120, Issue SUPPL. 1, 1999, Pages 65-69

  Fujisawa, Takao ^a,b   Kato, Yoshiko ^a   Terada, Akihiko ^a   Iguchi, Kosei ^a   Kamiya, Hitoshi ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MIE NATIONAL HOSPITAL   (Japan)

Author keywords

Eosinophils; IL 5; Matrix metalloproteinase 9; Neutrophils; Phorbol myristate acetate

Indexed keywords

CD16 ANTIGEN; GELATIN; GELATINASE B; INTERLEUKIN 5; MATRIX METALLOPROTEINASE; PHORBOL 13 ACETATE 12 MYRISTATE; THROMBOCYTE ACTIVATING FACTOR;

ALLERGY; ASTHMA; CENTRIFUGATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LEUKOCYTE; MONONUCLEAR CELL; NEUTROPHIL; PRIORITY JOURNAL; ZYMOGRAPHY;

ASTHMA; EOSINOPHILS; HUMANS; LEUKOCYTES; MATRIX METALLOPROTEINASE 9;

EID: 0032852284     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053598     Document Type: Conference Paper

References (12)

1. Stetler-Stevenson WG: Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol 1996;148: 1345-1350.
2. Liotta LA, Stetler-Stevenson WG: Metalloproteinases and cancer invasion. Cancer Biol 1990;1:99-106.
3. Ohno I, Ohtani H, Nitta Y, Suzuki J, Hoshi H, Honma M, Isoyama S, Tanno Y, Tamura G, Yamauchi K, Nagura H, Shirato K: Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997;16:212-219.
4. Mautino G, Oliver N, Chanez P, Bousquet J, Capony F: Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol 1997;17:583-591.
5. Atsuta J, Fujisawa T, Iguchi K, Terada A, Kamiya H, Sakurai M: Inhibitory effect of transforming growth factor beta1 on cytokine-enhanced eosinophil survival and degranulation. Int Arch Allergy Immunol 1995; 108(suppl 1):31-35.
6. Romanic AM, Madri JA: The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J Cell Biol 1994;125:1165-1178.
7. Stahle-Backdahl M, Inoue M, Giudice GJ, Parks WC: 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J Clin Invest 1994; 93:2022-2030.
8. Partridge CA, Jeffrey JJ, Malik AB: A 96-kDa gelatinase induced by TNF-alpha contributes to increased microvascular endothelial permeability. Am J Physiol 1993;265:438-447.
9. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL: T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995;154:4379-4389.
10. Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM: Migration of eosinophils through basement membrane components in vitro: Role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997;17:519-528.
11. Herbert CA, Arthur MJP, Robinson C: Augmentation by eosinophils of gelatinase activity in the airway mucosa: Comparative effects as a putative mediator of eosinophil injury. Br J Clin Pharmacol 1996;117:667-674.
12. Roche WR, Beasley R, Williams J, Holgate ST: Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989;8637:520-524.